| Dr Maridoli Caceres Kianes, MD | |
|
Urb Estancias De Monte Rio, Box 99, Cayey, PR 00736-0073 | |
| (787) 535-3826 | |
| Not Available |
| Full Name | Dr Maridoli Caceres Kianes |
|---|---|
| Gender | Female |
| Speciality | General Practice |
| Location | Urb Estancias De Monte Rio, Cayey, Puerto Rico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194233601 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 019823 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Maridoli Caceres Kianes, MD Urb Estancias De Monte Rio, Box 99, Cayey, PR 00736 Ph: (787) 535-3826 | Dr Maridoli Caceres Kianes, MD Urb Estancias De Monte Rio, Box 99, Cayey, PR 00736-0073 Ph: (787) 535-3826 |
News Archive
Mutation of a gene involved in non-small cell lung cancer (NSCLC) increases the likelihood that the drug gefitinib (Iressa™) will show a beneficial response, researchers at the Dana-Farber Cancer Institute, the National Cancer Institute (NCI) - part of the National Institutes of Health - and two other institutions announced today in the online version of Science.
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least 40 kilograms [about 88 pounds]) with positive results of direct SARS-CoV-2 viral testing and who are at high risk for progressing to severe COVID-19.
In the shadows of Covid travel restrictions, a 42-acre park on the far western edge of the U.S.-Canadian dividing line has become a popular opening in an otherwise closed border, a place where Americans and Canadians can gather without needing permission to go through an official border crossing.
ReachBio LLC announced today the launch of HemoRANK(TM)-TKI, an in vitro assay service package that helps predict the potential of novel therapeutic tyrosine kinase inhibitors (TKIs) to cause clinical hematotoxicity (myelotoxicity or neutropenia).
A new microscope system can image living tissue in real time and in molecular detail, without any chemicals or dyes, report researchers at the University of Illinois.
› Verified 9 days ago
Dr. Wilfredo Adorno, M.D. General Practice Medicare: Medicare Enrolled Practice Location: Bo Beatriz Km 49 1 Carretera Num 1, Cayey, PR 00737 Phone: 787-640-6226 | |
Jose M Figueroa Robles, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 55 Calle Manuel Corchado, Cayey, PR 00736 Phone: 787-689-0600 Fax: 787-738-8700 | |
Dr. Jose Rafael Rodriguez, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: Mansiones Monte Verde, Marta St. #255, Cayey, PR 00736 Phone: 787-361-7053 Fax: 787-535-9171 | |
Dr. Carlos A Quiles Aponte, M.D General Practice Medicare: Accepting Medicare Assignments Practice Location: Ave Antonio R Barcelo # Km716, Carr 14, Cayey, PR 00736 Phone: 787-738-5764 | |
Janice Figueroa Diaz, MD General Practice Medicare: Medicare Enrolled Practice Location: 154 La Borinquena D16, Mansiones Monte Verde, Cayey, PR 00737 Phone: 787-392-1060 | |
Dr. Gremarie Rivera Flores, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 23007 Carr 743, Cayey, PR 00736 Phone: 787-204-1883 | |
Yaritza Gloriana Suarez Rodriguez, MD General Practice Medicare: Medicare Enrolled Practice Location: 64 Calle Jose Celso Barbosa S, Cayey, PR 00736 Phone: 787-738-1833 |